Plant compound slows cervical cancer growth in preclinical model

Cervical cancer is one of the most common gynecologic cancers worldwide and continues to be a leading cause of cancer-related death in women. While early detection through screening has improved outcomes, treatment options for advanced or recurrent disease remain limited. The five-year survival rate for late-stage cervical cancer is still less than 20%, underscoring the urgent need for better therapies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup